Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Lupus nephritis
MeSH D008181 - lupus nephritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008180:
Systemic lupus erythematosus
141 Companies
22 Drugs
$
Success rate
D005921:
Glomerulonephritis
55 Companies
15 Drugs
$
Success rate
D008181:
Lupus nephritis
21 Companies
2 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
63
%
5/8
Phase 2
62
%
28/45
Phase 3
34
%
14/41
Approved:
3
Overall Success rate:
13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cyclophosphamide
,
Mycophenolate sodium
,
Laquinimod
,
Tiratricol
,
Microcrystalline cellulose
,
Solumedrol
Aurinia Pharmaceuticals
Voclosporin
,
Mycophenolate sodium
,
Bevifimod
Baxter
Cyclophosphamide
Jiangsu Hengrui Medicine
Cyclophosphamide
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use